PreformulationCharacterizing the physicochemical properties of a therapeutic candidate is the foundation of successfully developing robust formulations. Typical preformulation studies include crystallization, polymorphism, salt selection, and solubility. Most efforts in these studies are limited by labor-intensive, manual experimentations. Through its automated and configurable Core Module 3 (CM3) robotic platform, Freeslate enables you to conduct all your preformulation studies on a single product in a high throughput manner. With the CM3-based Preformulation System, you can increase the number of crystallization and solubility studies completed per year by a factor of 10. For polymorph screens, the process of finding a suitable crystalline form is accelerated while reducing the risk of late stage failure from emergence of new metastable forms. For salt screens, a broader examination of reaction conditions and solvent systems is achieved, optimizing effectively the crystallization process. Combined with Freeslate Lab Execution and Analysis (LEA) software, the Preformulation System accelerates your preformulation process (experiment design, preformulation study, and data analysis), maximizing your R&D productivity. Product DocumentsFor more detailed product information, please submit your inquiry and our technical specialists will contact you shortly. Learning CenterWebinars
Case Studies
Application NotesClick here to view complete set of CM3 elements. For more detailed product information, please submit your inquiry and our technical specialists will contact you shortly. Close
Close
Close
Contact Freeslate:
|
|

